Pasithea Therapeutics Corp. (KTTAW) Other Non Operating Income (2022 - 2026)

Pasithea Therapeutics has disclosed Other Non Operating Income across 5 years of filings, most recently posting $38182.0 for Q2 2026.

• In Q2 2026, Other Non Operating Income rose 30.36% year-over-year to $38182.0; the TTM figure through Jun 2026 stood at $388564.0 (up 27.85% YoY), while the FY2025 annual figure was $380532.0, changed N/A from the prior year.
• Other Non Operating Income came in at $38182.0 for Q2 2026 at Pasithea Therapeutics, up from $24183.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $352449.0 in Q4 2025 to a low of -$26250.0 in Q3 2025.
• Average Other Non Operating Income over 5 years is $70667.1, with a median of $33736.0 recorded in 2025.
• Year-over-year, Other Non Operating Income plunged 114.2% in 2023 and soared 2498.53% in 2024.
• Over 5 years, Other Non Operating Income stood at -$277.0 in 2022, then soared by 42407.22% to $117191.0 in 2023, then retreated by 2.38% to $114407.0 in 2024, then surged by 208.07% to $352449.0 in 2025, then slumped by 89.17% to $38182.0 in 2026.
• Per Business Quant data, the three most recent Other Non Operating Income figures were $38182.0 in Q2 2026, $24183.0 in Q1 2026, and $352449.0 in Q4 2025.